SAMEOVA

SAMEOVA is a multi-ingredient nutraceutical supplement developed by Adorshea Bioceutics, specifically formulated to support women with poor ovarian reserve and infertility. The product typically combines micronized dehydroepiandrosterone (DHEA), folic acid, and vitamin D3 (cholecalciferol). DHEA serves as a pro-hormone precursor that is converted into androgens and estrogens within the ovarian follicles, which is thought to improve the follicular microenvironment, enhance oocyte quality, and increase the number of follicles available for recruitment during assisted reproductive technology (ART) cycles. Folic acid and Vitamin D3 provide essential nutritional support for DNA synthesis and overall reproductive health. SAMEOVA is distinct from SAMEOVA L5, which is a formulation of the aromatase inhibitor letrozole used for ovulation induction.

Brand names

SAMEOVA

Other names

SAMEOVADHEA + Folic Acid + Vitamin D3